Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001137 · ClinicalTrials.gov registry record
Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
A clinical trial, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- Completed
- Registry status
- 5,982
- Enrollment target
NCT00001137: Completed study, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
NCT00001137 is a clinical trial that has completed, run by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. The registered enrollment target is 5,982 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001137 has completed, sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.
- COMPLETED
- Registry status
- 5,982 participants
- Enrollment target
Study Summary
The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,982 participants |
| Start Date | 2000-01 |
| Est. Completion | 2013-11 |
What the finished NCT00001137 record still lists
NCT00001137 is an observational study that tracks outcomes without assigning an intervention. Its 5,982 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001137 about?
NCT00001137 is a clinical study titled "Long-Term Data Collection From Participants in Adult AIDS Clinical Trials". The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.
What is the current status of trial NCT00001137?
This trial is currently completed. The enrollment target is 5,982 participants. The study started on 2000-01. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT00001137?
This trial is sponsored by Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06192511 · 5,980 participants · NA
Implementing a Novel Consent Process for Biospecimen Research After Newborn Screening
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia